Literature DB >> 8440063

Ulcerating necrobiosis lipoidica effectively treated with pentoxifylline.

K C Noz1, M J Korstanje, B J Vermeer.   

Abstract

A 30-year-old man had suffered from persistent ulceration within an area of necrobiosis lipoidica diabeticorum for 13 months. The ulcerating necrobiosis lipoidica was resistant to topical therapy and oral therapy with acetylsalicylic acid. However, the ulcers healed completely within 8 weeks of administration of 400 mg pentoxifylline twice daily.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440063     DOI: 10.1111/j.1365-2230.1993.tb00977.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

Review 1.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

2.  Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.

Authors:  Cindy Franklin; Maren Stoffels-Weindorf; Uwe Hillen; Joachim Dissemond
Journal:  Int Wound J       Date:  2013-10-07       Impact factor: 3.315

3.  Necrobiosis lipoidica diabeticorum: response to pentoxiphylline.

Authors:  S Basaria; M Braga-Basaria
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

4.  Healing of chronic necrobiosis lipoidica lesions in a type 1 diabetic patient after pancreas-kidney transplantation: a case report.

Authors:  D Gullo; A Latina; L Tomaselli; M L Arpi; S Squatrito; S Curatolo; S La Greca; R Vigneri
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

5.  Pentoxifylline and its applications in dermatology.

Authors:  Iffat Hassan; Konchok Dorjay; Parvaiz Anwar
Journal:  Indian Dermatol Online J       Date:  2014-10

Review 6.  Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review.

Authors:  Amir Feily; Shadi Mehraban
Journal:  Dermatol Reports       Date:  2015-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.